Apimeds Pharmaceuticals Us, INC. (APUS) — 10-K/A Filings
All 10-K/A filings from Apimeds Pharmaceuticals Us, INC.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
Apimeds Pharmaceuticals Files 10-K Amendment
— May 2, 2025 Risk: low
Apimeds Pharmaceuticals US, Inc. filed an amendment (Amendment No. 1) to its annual report on Form 10-K for the fiscal year ended December 31, 2024. The filing,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX